Cargando…

IL-17A, IL-22, IL-6, and IL-21 Serum Levels in Plaque-Type Psoriasis in Brazilian Patients

Psoriasis is a chronic inflammatory skin disease characterized by alterations in cytokines produced by both Th1 and Th17 pathways. The aim of this study was to evaluate serum levels of pivotal cytokines and correlate them with clinical parameters. Serum samples from 53 psoriasis patients and 35 heal...

Descripción completa

Detalles Bibliográficos
Autores principales:	de Oliveira, Priscilla Stela Santana, Cardoso, Pablo Ramon Gualberto, Lima, Emerson Vasconcelos de Andrade, Pereira, Michelly Cristiny, Duarte, Angela Luzia Branco Pinto, Pitta, Ivan da Rocha, Rêgo, Moacyr Jesus Barreto de Melo, Pitta, Maira Galdino da Rocha
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4550763/ https://www.ncbi.nlm.nih.gov/pubmed/26351408 http://dx.doi.org/10.1155/2015/819149

Ejemplares similares

Synthesis of a Novel Thiazolidinedione and Evaluation of Its Modulatory Effect on IFN-γ, IL-6, IL-17A, and IL-22 Production in PBMCs from Rheumatoid Arthritis Patients
por: da Rocha Junior, Laurindo Ferreira, et al.
Publicado: (2013)

Increased IL17A, IFNG, and FOXP3 Transcripts in Moderate-Severe Psoriasis: A Major Influence Exerted by IL17A in Disease Severity
por: de Oliveira, Priscilla Stela Santana, et al.
Publicado: (2016)

Cratylia mollis 1, 4 Lectin: A New Biotechnological Tool in IL-6, IL-17A, IL-22, and IL-23 Induction and Generation of Immunological Memory
por: de Oliveira, Priscilla Stela Santana, et al.
Publicado: (2013)

Losartan, but not Enalapril and Valsartan, Inhibits the Expression of IFN-γ, IL-6, IL-17F and IL-22 in PBMCs from Rheumatoid Arthritis Patients
por: Cardoso, Pablo R. G., et al.
Publicado: (2018)

Galectin-9 gene (LGALS9) polymorphisms are associated with rheumatoid arthritis in Brazilian patients
por: Vilar, Kamila de Melo, et al.
Publicado: (2019)

The Role of PPAR Gamma in Systemic Sclerosis
por: Dantas, Andréa Tavares, et al.
Publicado: (2015)

Galectin-1, -4, and -7 Were Associated with High Activity of Disease in Patients with Rheumatoid Arthritis
por: Vilar, Kamila de Melo, et al.
Publicado: (2019)

Diminuição dos Níveis Séricos do Receptor Solúvel da Oncostatina M (sOSMR) e Glicoproteína 130 (sgp130) em Pacientes com Doença Arterial Coronariana
por: de Carvalho, Vanessa Mylenna Florêncio, et al.
Publicado: (2023)

PPARγ Agonists in Adaptive Immunity: What Do Immune Disorders and Their Models Have to Tell Us?
por: da Rocha Junior, Laurindo Ferreira, et al.
Publicado: (2013)

Evaluation of long-term stability of SARS-CoV-2 nucleic acid extracted from human nasopharyngeal samples
por: de Oliveira, Priscilla Stela Santana, et al.
Publicado: (2022)

Interleukin-18 in Brazilian Rheumatoid Arthritis Patients: Can Leflunomide Reduce It?
por: Gualberto Cardoso, Pablo Ramon, et al.
Publicado: (2021)

Enhanced rapid commercial DNA extraction kit for the molecular detection of severe acute respiratory syndrome coronavirus 2: Easy adaptation to current protocols
por: Pessoa-e-Silva, Rômulo, et al.
Publicado: (2021)

Reassessing the Role of the Active TGF-β1 as a Biomarker in Systemic Sclerosis: Association of Serum Levels with Clinical Manifestations
por: Dantas, Andréa Tavares, et al.
Publicado: (2016)

Hydroxychloroquine decreases Th17-related cytokines in systemic lupus erythematosus and rheumatoid arthritis patients
por: da Silva, Juliana Cruz, et al.
Publicado: (2013)

Immunopositivity for Siglec-15 in gastric cancer and its association with clinical and pathological parameters
por: Quirino, Michael Williams Leal, et al.
Publicado: (2021)

Increased Serum Interleukin-9 Levels in Rheumatoid Arthritis and Systemic Lupus Erythematosus: Pathogenic Role or Just an Epiphenomenon?
por: Dantas, Andréa Tavares, et al.
Publicado: (2015)

Synthesis and biological evaluation of novel imidazolidine derivatives as candidates to schistosomicidal agents
por: Matos-Rocha, Thiago José, et al.
Publicado: (2017)

Polymorphisms in IL36G gene are associated with plaque psoriasis
por: Traks, Tanel, et al.
Publicado: (2019)

Role of IL-17 in plaque psoriasis: therapeutic potential of ixekizumab
por: Hanley, Tessa L, et al.
Publicado: (2017)

A Review of Biologic Therapies Targeting IL-23 and IL-17 for Use in Moderate-to-Severe Plaque Psoriasis
por: Campa, Molly, et al.
Publicado: (2015)

Influence of IL10 (rs1800896) Polymorphism and TNF-α, IL-10, IL-17A, and IL-17F Serum Levels in Ankylosing Spondylitis
por: Braga, Matheus, et al.
Publicado: (2021)

Erratum to: A Review of Biologic Therapies Targeting IL-23 and IL-17 for Use in Moderate-to-Severe Plaque Psoriasis
por: Campa, Molly, et al.
Publicado: (2016)

Evaluating guselkumab: an anti-IL-23 antibody for the treatment of plaque psoriasis
por: Yang, Eric J, et al.
Publicado: (2019)

The IL-17 Family of Cytokines in Psoriasis: IL-17A and Beyond
por: Brembilla, Nicolo Costantino, et al.
Publicado: (2018)

The Significance of IL-36 Hyperactivation and IL-36R Targeting in Psoriasis
por: Madonna, Stefania, et al.
Publicado: (2019)

An Analysis of IL-10, IL-17A, IL-17RA, IL-23A and IL-23R Expression and Their Correlation with Clinical Course in Patients with Psoriasis
por: Kutwin, Magdalena, et al.
Publicado: (2021)

Serum Levels of TNF-α, IL-12/23p40, and IL-17 in Plaque Psoriasis and Their Correlation with Disease Severity
por: Kyriakou, Aikaterini, et al.
Publicado: (2014)

Genetic characterization of interleukins (IL-1α, IL-1β, IL-2, IL-4, IL-8, IL-10, IL-12A, IL-12B, IL-15 and IL-18) with relevant biological roles in lagomorphs
por: Neves, Fabiana, et al.
Publicado: (2015)

Association of IL-9, IL-10, and IL-17 Cytokines With Hepatic Fibrosis in Human Schistosoma mansoni Infection
por: Franco, Karine Garcez Schuster, et al.
Publicado: (2021)

Serum Levels of TNF-α, IFN-γ, IL-6, IL-8, IL-12, IL-17, and IL-18 in Patients With Active Psoriasis and Correlation With Disease Severity
por: Arican, Ozer, et al.
Publicado: (2005)

Association of Polymorphisms of IL-6 Pathway Genes (IL6, IL6R and IL6ST) with COVID-19 Severity in an Amazonian Population
por: Rodrigues, Fabíola Brasil Barbosa, et al.
Publicado: (2023)

The Impact of Treatment with IL-17/IL-23 Inhibitors on Subclinical Atherosclerosis in Patients with Plaque Psoriasis and/or Psoriatic Arthritis: A Systematic Review
por: Tsiogka, Aikaterini, et al.
Publicado: (2023)

Peroxisome proliferator-activated receptor agonists (PPARs): a promising prospect in the treatment of psoriasis and psoriatic arthritis
por: Lima, Emerson de Andrade, et al.
Publicado: (2013)

Transcriptional landscape of psoriasis identifies the involvement of IL36 and IL36RN
por: Keermann, Maris, et al.
Publicado: (2015)

Mast Cell Cytokines IL-1, IL-33, and IL-36 Mediate Skin Inflammation in Psoriasis: A Novel Therapeutic Approach with the Anti-Inflammatory Cytokines IL-37, IL-38, and IL-1Ra
por: Conti, Pio, et al.
Publicado: (2021)

The role of IL-23 in the immunopathogenesis of psoriasis
por: Meglio, Paola Di, et al.
Publicado: (2010)

Regulation of IL-22BP in psoriasis
por: Voglis, Stefanos, et al.
Publicado: (2018)

The Role of IL-17 Cytokines in Psoriasis
por: Mosca, Megan, et al.
Publicado: (2021)

New and emerging biologic therapies for moderate-to-severe plaque psoriasis: mechanistic rationales and recent clinical data for IL-17 and IL-23 inhibitors
por: Gaspari, Anthony A, et al.
Publicado: (2015)

Development, Characterization, and Immunomodulatory Evaluation of Carvacrol-loaded Nanoemulsion
por: Dantas, Amanda Gabrielle Barros, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_m1p6nlfvnjiag5k35vtf56ekn5